Tetrahydropalmatine is under investigation in clinical trial NCT02118610 (Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity).
Tetrahydropalmatine is under investigation in clinical trial NCT02118610 (Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity).
用于胃肠及肝胆系统内科疾病所引起的钝痛,一般性头痛以及脑震荡后头痛等;也可用于月经痛及分娩止痛。
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.